Alert detail
FDA Approval: ZUEINO (DICLOFENAC SODIUM) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA218379Specialty: Pain ManagementAdded: 10/2/2026Effective: September 25, 2026billing update
What changed
IV diclofenac sodium approved; watch for new J-code assignment.
Who’s affected: Pain Management billing teams · Effective: September 25, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.